HCPCS Code J9199

Injection, gemcitabine hydrochloride (infugem), 200 mg
Code effective Jul 01, 2020

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J9199 is a valid 2026 HCPCS code meaning Injection, gemcitabine hydrochloride (infugem), 200 mg or (Injection, infugem, 200 mg) for short. HCPCS J9199 has been effective since 07/01/2020 and applies to Medical care.

HCPCS Code Details - J9199

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9199
Description

Long description:
Injection, gemcitabine hydrochloride (infugem), 200 mg

Short description:
Injection, infugem, 200 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2020
Date added Added Jan 01, 2020
Termination date Jun 30, 2020

See also

  • HCPCS J9184 · Injection, gemcitabine hydrochloride (avyxa), 200 mg

  • HCPCS J9196 · Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

  • HCPCS J9198 · Injection, gemcitabine hydrochloride, (infugem), 100 mg

  • HCPCS J9201 · Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

  • HCPCS J9200 · Injection, floxuridine, 500 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/13/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.